These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 39004987)

  • 1. [Current status of palliative care for patients with unresectable metastatic colorectal cancer in China: a questionnaire-based survey].
    Wang F; Chen DL; Wang ZX; He Y; Li J; Zhang SZ; Chen G; Xu JM; Yuan XL; Zhang YQ; Xu RH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Jul; 27(7):718-725. PubMed ID: 39004987
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sampling survey report on Chinese physicians' cognition of the guidelines on diagnosis and treatment of colorectal cancer].
    Gao ZY; Li M; Gu J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Nov; 23(11):1067-1073. PubMed ID: 33212555
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment patterns and direct medical costs of metastatic colorectal cancer patients: a retrospective study of electronic medical records from urban China.
    Shen L; Li Q; Wang W; Zhu L; Zhao Q; Nie Y; Zhu B; Ma D; Lin X; Cai X; Fang W; Peng C; Chen Y; Fang H; Yin Z; Li H; Wang N; Xu R
    J Med Econ; 2020 May; 23(5):456-463. PubMed ID: 31950863
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reassessment of practice of Chinese surgeons since introduction of the watch and wait strategy after neoadjuvant therapy for rectal cancer].
    Zhao MH; Sun TT; Wang L; Huang YL; Xie XY; Lu Y; Zhao GH; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):383-394. PubMed ID: 38644244
    [No Abstract]   [Full Text] [Related]  

  • 5. Inventory of oncologists' unmet needs for tools to support decision-making about palliative treatment for metastatic colorectal cancer.
    Engelhardt EG; Révész D; Tamminga HJ; Punt CJA; Koopman M; Onwuteaka-Philipsen BD; Steyerberg EW; de Vet HCW; Coupé VMH
    BMC Med Inform Decis Mak; 2018 Dec; 18(1):132. PubMed ID: 30551735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease characteristics and treatment patterns of Chinese patients with metastatic colorectal cancer: a retrospective study using medical records from China.
    Xu R; Wang W; Zhu B; Lin X; Ma D; Zhu L; Zhao Q; Nie Y; Cai X; Li Q; Fang W; Li H; Wang N; Chen Y; Peng C; Fang H; Shen L
    BMC Cancer; 2020 Feb; 20(1):131. PubMed ID: 32070312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How are elderly patients treated after a diagnosis of metastatic colorectal cancer in real-life practice? A study in a French teaching hospital.
    Gouverneur A; Rouyer M; Grelaud A; Robinson P; Colombani F; Terrebonne E; Smith D; Fourrier-Réglat A; Noize P
    Fundam Clin Pharmacol; 2017 Feb; 31(1):104-109. PubMed ID: 27600062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing health-state utility values in patients with metastatic colorectal cancer: a utility study in the United Kingdom and the Netherlands.
    Stein D; Joulain F; Naoshy S; Iqbal U; Muszbek N; Payne KA; Ferry D; Goey SH
    Int J Colorectal Dis; 2014 Oct; 29(10):1203-10. PubMed ID: 25080148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consideration of Metastasis-Directed Therapy for Patients With Metastatic Colorectal Cancer: Expert Survey and Systematic Review.
    Miller ED; Klamer BG; Cloyd JM; Pawlik TM; Williams TM; Hitchcock KE; Romesser PB; Mamon HJ; Ng K; Gholami S; Chang GJ; Anker CJ
    Clin Colorectal Cancer; 2024 Jun; 23(2):160-173. PubMed ID: 38365567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Use and Perceptions About Triplet Chemotherapy Plus Bevacizumab for Metastatic Colorectal Cancer.
    van Nassau SC; Bond MJ; Scheerman I; van Breeschoten J; Kessels R; Valkenburg-van Iersel LB; Verheul HM; Buffart TE; Mekenkamp LJ; Lemmens VE; Koopman M; Bol GM;
    JAMA Netw Open; 2021 Sep; 4(9):e2124766. PubMed ID: 34505885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Screening and COnsensus Based on Practices and Evidence (SCOPE) Program-Results of a Survey on Daily Practice Patterns for Patients with mCRC.
    Prager G; Köhne CH; O'Connor JM; Rivera F; Santini D; Wasan H; Phelip JM
    Curr Oncol; 2021 Jun; 28(3):2097-2106. PubMed ID: 34199694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Panitumumab use in metastatic colorectal cancer and patterns of RAS testing: results from a Europe-wide physician survey and medical records review.
    Han van Krieken J; Kafatos G; Bennett J; Mineur L; Tomášek J; Rouleau E; Fabian P; De Maglio G; García-Alfonso P; Aprile G; Parkar P; Downey G; Demonty G; Trojan J
    BMC Cancer; 2017 Nov; 17(1):798. PubMed ID: 29183279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of Oral Therapeutics in China for the Treatment of Colorectal Cancer.
    Li J; Cai Y; Deng Y
    Curr Treat Options Oncol; 2021 Jun; 22(7):55. PubMed ID: 34097129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of palliative chemotherapy in metastatic colorectal cancer patients with an ECOG performance status of 3 and 4.
    Crosara Teixeira M; Marques DF; Ferrari AC; Alves MF; Alex AK; Sabbaga J; Hoff PM; Riechelmann RP
    Clin Colorectal Cancer; 2015 Mar; 14(1):52-7. PubMed ID: 25442812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-world treatment patterns and outcomes in refractory metastatic colorectal cancer.
    Chiang CL; Choi HC; Lam KO; Chan BY; Lee SF; Yeung SY; Lau KS; Chan SY; Choy TS; Yuen KK
    Asia Pac J Clin Oncol; 2019 Mar; 15 Suppl 2():5-13. PubMed ID: 30887726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRAS Testing for Anti-EGFR Therapy in Advanced Colorectal Cancer: An Evidence-Based and Economic Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(25):1-49. PubMed ID: 23074403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical Trial.
    Chauhan N; Mulcahy MF; Salem R; Benson Iii AB; Boucher E; Bukovcan J; Cosgrove D; Laframboise C; Lewandowski RJ; Master F; El-Rayes B; Strosberg JR; Sze DY; Sharma RA
    JMIR Res Protoc; 2019 Jan; 8(1):e11545. PubMed ID: 30664496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare costs associated with bevacizumab and cetuximab in second-line treatment of metastatic colorectal cancer.
    Yang H; Yu AP; Wu EQ; Yim YM; Yu E
    J Med Econ; 2011; 14(5):542-52. PubMed ID: 21728912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.